Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Failures in tablet content uniformity and process understanding
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: BARROCAS, Pedro (Bial - Portela & Cª, S.A., R&D Department - Pharmaceutical development, Trofa, Portugal)
- Co-author(s): Pedro Barrocas: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Teofilo Vasconcelos: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Patrício Soares-da-Silva: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Ricardo Lima: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
BackgroundsContent uniformity is one of the most important Critical Quality Attributes in a pharmaceutical form, as it is the basis to assure dose-to-dose reproducibility. Obtaining a compliant content uniformity is, in some cases, a difficult task.
AimsThe present work summarizes the difficulties in achieving an adequate content uniformity in a.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019